Also, in 2022, a novel phthalocyanine-based photosensitizer, ZnPc-MLB, was rationally designed to target monoamine oxidase A (MAO-A), an enzyme known to be overexpressed in prostate cancer. This evidence concerns the gene MAOA and prostate cancer.